Welcome to the Patient Support Program.
Diabetes
Supports Type 1 or Type 2 diabetes patients prescribed a Novo Nordisk insulin treatment.
Growth Hormone
Supports patients who have been prescribed a Novo Nordisk growth hormone treatment. Virtual education sessions are provided by registered nurses.
Important Update regarding NovoCare®
Please be advised that, effective 16 October 2025, patient support services currently offered via NovoCare® will be migrated to a new platform.
The last day for NovoCare® enrolments will be 13 October, with final NovoCare® nurse education sessions taking place on 15 October.
For further information, please contact Novo Nordisk Medical Information at aunrccc@novonordisk.com or 1800 668 626.
